Evidence map›Paper›PMID 18454195›Full record

ArticlePLoS genetics2008

Identification of genetic and chemical modulators of zebrafish mechanosensory hair cell death.

Kelly N Owens, Felipe Santos, Brock Roberts, Tor Linbo, Allison B Coffin, Anna J Knisely, Julian A Simon, Edwin W Rubel, David W Raible

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05730283 (Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Drug-Induced Hearing Loss in Patients Receiving Intravenous Amikacin Therapy for Non-Tuberculous Mycobacterium Disease), which is not on this map. Cited by 122 papers.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05730283 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Drug-Induced Hearing Loss in Patients Receiving Intravenous Amikacin Therapy for Non-Tuberculous Mycobacterium Disease

TypeinterventionalSponsorKevin WinthropRan2025 to 2028Enrolled105ConditionsOtotoxicity, Drug-InducedArmsORC-13661, Placebo
3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 218 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pharmacological Approaches to Hearing Loss.Pharmacological reviews · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Frontiers in pharmacology · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. The BDNF/TrkB Neurotrophin System in the Sensory Organs of Zebrafish.International journal of molecular sciences · 2022
    Review
  19. AnFrontiers in molecular neuroscience · 2022
    Article
  20. Review

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kelly N OwensDepartment of Biological Structure, University of Washington, Seattle, Washington, United States of America.
Felipe Santos
Brock Roberts
Tor Linbo
Allison B Coffin
Anna J Knisely
Julian A Simon
Edwin W Rubel
David W Raible
University of Washington · USFred Hutch Cancer Center · US

Funding

UNIVERSITY OF WASHINGTON RESEARCH CORE CENTERP30DC004661 · NIDCD · UNIVERSITY OF WASHINGTON · PI WERNER, LYNNE A. · 2000 to 2014
$11.1M
Genetics of Zebrafish Hair Cell ToxicityR01DC005987 · NIDCD · UNIVERSITY OF WASHINGTON · PI RAIBLE, DAVID W · 2003 to 2023
$9.8M
Research Training in OtolaryngologyT32DC000018 · NIDCD · UNIVERSITY OF WASHINGTON · PI STONE, JENNIFER S. · 1989 to 2023
$7.8M
COGNITIVE/LINGUISTIC FACTORS IN ACQUIRED DYSLEXIAR01DC000699 · NIDCD · UNIVERSITY OF MARYLAND BALTIMORE · PI BERNDT, RITA SLOAN · 1989 to 2001
$515k
Modulation of hair cell toxicity in zebrafishF32DC006998 · NIDCD · UNIVERSITY OF WASHINGTON · PI OWENS, KELLY N · 2004 to 2005
$114k
Hair Cell ToxicityF32DC007244 · NIDCD · UNIVERSITY OF WASHINGTON · PI SANTOS, FELIPE · 2004 to 2004
$44k
NIDCD NIH HHS DC0018NIDCD NIH HHS DC00699NIDCD NIH HHS DC04661NIDCD NIH HHS DC05987NIDCD NIH HHS DC07244NIDCD NIH HHS F32 DC006998NIDCD NIH HHS F32 DC007244NIDCD NIH HHS P30 DC004661NIDCD NIH HHS R01 DC005987NIDCD NIH HHS T32 DC000018
6 · The paper itself

Abstract

Inner ear sensory hair cell death is observed in the majority of hearing and balance disorders, affecting the health of more than 600 million people worldwide. While normal aging is the single greatest contributor, exposure to environmental toxins and therapeutic drugs such as aminoglycoside antibiotics and antineoplastic agents are significant contributors. Genetic variation contributes markedly to differences in normal disease progression during aging and in susceptibility to ototoxic agents. Using the lateral line system of larval zebrafish, we developed an in vivo drug toxicity interaction screen to uncover genetic modulators of antibiotic-induced hair cell death and to identify compounds that confer protection. We have identified 5 mutations that modulate aminoglycoside susceptibility. Further characterization and identification of one protective mutant, sentinel (snl), revealed a novel conserved vertebrate gene. A similar screen identified a new class of drug-like small molecules, benzothiophene carboxamides, that prevent aminoglycoside-induced hair cell death in zebrafish and in mammals. Testing for interaction with the sentinel mutation suggests that the gene and compounds may operate in different pathways. The combination of chemical screening with traditional genetic approaches is a new strategy for identifying drugs and drug targets to attenuate hearing and balance disorders.

Indexed as

AminoglycosidesAnimalsBase SequenceCell DeathCisplatinCodon, TerminatorDNA, ComplementaryDNA PrimersDrug Evaluation, PreclinicalEpistasis, GeneticHair Cells, Auditory, InnerHearing LossHumansMiceNeomycinPoint MutationAminoglycosidesCisplatinCodon, TerminatorDNA, ComplementaryDNA PrimersNeomycinThiophenes

Identifiers

PMID18454195
PMCPMC2265478
OpenAlexW2072316722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.